Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Amplifications (MATCH-Subprotocol K1)
Clinical trial NCT06308822 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06308822
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-20
- Primary completion
- 2022-07-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.